Search
for
Sort by
Research 661–690 of 1000+
- Effects of 1?,25-dihydroxy-vitamin D3 and calcipotriol on organotypic cultures of outer root sheath cells: a potential model to evaluate antipsoriatic drugs
- The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
- The Role of Janus Kinase Inhibitors in Dermatology
- Genomewide Scan for Linkage Reveals Evidence of Several Susceptibility Loci for Alopecia Areata
- Nutritional Clinical Studies in Dermatology
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update
- Deep skin fibroblast-mediated macrophage recruitment supports acute wound healing
- TREATMENT PEARLS FROM EUROPE
- Subject Index
- Highlights from the 68th Annual Meeting of the Society of Investigative Dermatology
- Dermoscopy: what's new?
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Issue Information
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Dermatologic therapy: December 1986 to December 1987
- Dermatological drugs, topical agents, and cosmetics
- The role of VEGF and thrombospondins in skin angiogenesis
- Novel Technologies for Exploring the Skin–Brain Axis
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Phospholipase A2 in skin biology: new insights from gene-manipulated mice and lipidomics
- Skin-associated adipocytes in skin barrier immunity: A mini-review
- Recent advances in understanding the role of the skin microbiome in the treatment of atopic dermatitis
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Endocrine systems of the skin
- Extracellular Vesicles in Skin: Biological Function and Therapeutic Potential
- Metabolic Syndrome and Skin Diseases
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis